about
Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cellsThe ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancerGPER Signaling in Spermatogenesis and Testicular TumorsUse of aromatase inhibitors in practice of gynecologyMechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNAClinical utilities of aromatase inhibitors in breast cancerAcupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysisTargeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancerIRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumorsAromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast CancerAlcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer CellsSelective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cellsTranscriptional regulation prediction of antiestrogen resistance in breast cancer based on RNA polymerase II binding data.Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells.Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesisThe SMRT coregulator enhances growth of estrogen receptor-α-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis.Management options of breast cancer related osteoporosis.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions.A Brief History of Breast Cancer: Part III - Tumour biology lays the foundation for medical oncologyTargeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell deathAurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells.Estrogen receptor mutations and their role in breast cancer progressionInfluence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.How can grafted breast cancer models be optimized?High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein BimMicroenvironment and endocrine resistance in breast cancer: Friend or foe?Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.SEARCHBreast: a new resource to locate and share surplus archival material from breast cancer animal models to help address the 3Rs.Breast cancer in women using digoxin: tumor characteristics and relapse riskInhibition of estrogen biosynthesis enhances lymphoma growth in mice.miRNA clusters as therapeutic targets for hormone-resistant breast cancer.Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation.Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.Understanding breast cancer - The long and winding road.Post-transcriptional regulation of human breast cancer cell proteome by unliganded estrogen receptor β via microRNAs
P2860
Q24319134-FE717417-26F7-4D32-BD53-7880556D436AQ26786704-98F4AE79-8927-485B-9E0B-CBA3DAA8467CQ26865327-840BD06D-DC6B-46A2-9F22-393FBBA5CC91Q27001218-B9DA9D90-F5A8-4CAD-A0FB-BCF3CA9D2BB5Q27011221-AAD87FB5-59DF-4847-9C69-DB08489DA10CQ28081168-D5DC4634-95EF-4383-B2FB-48A260ADBACDQ28087204-A9D8BCC1-0C34-42FE-B5F9-E7F6FA53E71AQ28271388-70734E82-1367-4904-97E3-4705CAA9FD36Q28288521-9B4024E7-DF88-4282-A366-C81779483918Q28383028-45EB69B9-B0CE-4D18-8EED-156883A102B9Q28551506-1DCC9FC3-EA6F-4D50-85CC-8A60074F7182Q28567192-C1161FF6-D961-48A4-A22E-88C76FE02B7AQ30763243-D1BE6C7E-EFC1-4D29-B2A2-0DAB1BB90BB1Q33655922-576D3A34-60F4-4271-BE10-694C66EEDFF8Q33687329-5503A947-1B33-4627-8134-A8A80B1EC736Q33926671-98F9BB17-D4B1-48EB-8A7A-E78CC83644EEQ34068293-190309E3-2D71-4EC0-89D0-09E09ABC6727Q34230292-DAF5091D-FDAF-4465-B5B6-AE9D06844A54Q34437666-388A339B-BE2A-4D47-B1B2-01D268BBD636Q34648456-51409968-DC61-414D-9C8C-A861E569FB2EQ35054050-C61CF1D7-0327-4D66-B417-3487F7A7A46CQ35107727-EA4FFA61-D4E0-4A12-B48A-48B8740EBAADQ35558610-B17EFE86-132F-4EAC-B569-1AAFA49D06DEQ35599448-63FA62BC-A85A-4CF9-847D-CD837C76843BQ35661622-639906F1-2764-4CEC-8AF9-BD916618979FQ35760911-89F42ABC-5D49-49A3-8CFD-D92E2EF09165Q35797147-D15830F7-1B61-4A25-AAAA-21046E3F3A51Q36245560-A0232DAC-E674-480B-B498-B6E91DB68D8CQ36363626-8118EAAB-4653-4164-ABB7-88D55881F565Q36517144-0FCF75B3-6DE5-4A5F-9598-AF5E4FC7DFF2Q36525065-835F5C60-8F78-433F-895E-49937D2FDE6AQ36814409-10FEDF70-0FF6-4882-ACDC-B9B85D3FFC53Q36903225-9C9CB695-13C8-4EF8-BD5D-10494EAA0884Q37190419-7A3B02E2-B642-49A8-8A26-B30781CB2F44Q37316805-8A6CA149-9DB2-40BF-8C3B-B50FC6765A13Q37534910-AD6BB1E1-1A07-4CB1-9807-C0212305577EQ37624860-2E7688A0-0F54-47BF-85B5-DFB185A08CDBQ37627001-CE14A61A-BF09-4C1E-8551-5DC408B27695Q37634220-79EA40B1-543E-4862-AFE4-D02D5F2A84A7Q37687422-65CF43EF-2826-4EA9-B683-677F3475BBA8
P2860
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2011
@uk
name
Aromatase, aromatase inhibitors, and breast cancer
@en
Aromatase, aromatase inhibitors, and breast cancer
@nl
type
label
Aromatase, aromatase inhibitors, and breast cancer
@en
Aromatase, aromatase inhibitors, and breast cancer
@nl
prefLabel
Aromatase, aromatase inhibitors, and breast cancer
@en
Aromatase, aromatase inhibitors, and breast cancer
@nl
P2093
P2860
P1476
Aromatase, aromatase inhibitors, and breast cancer
@en
P2093
Angela Brodie
Saranya Chumsri
Timothy Howes
P2860
P356
10.1016/J.JSBMB.2011.02.001
P407
P577
2011-05-01T00:00:00Z